Development Project

DANIEL KLAMER, PH.D.

Uniquely talented Senior Research Pharmacologist combining outstanding industry and academic experience with business startup experience and talent for product development, commercialization. Creative innovator and “outside the box” thinker who is also a “people” person with outstanding communications talent and ability to develop and maintain harmonious relations across multiple functions and levels. Wide research, teaching and publication/presentation background in clinical and pre-clinical pharmacology. In-depth knowledge of pharmaceutical market trends; current research and special expertise in CNS with focus on schizophrenia, cognitive impairments and neurodegenerative disorders. Ph.D. in Pharmacology, Post-doctoral research fellowship at Yale University School of Medicine on cognitive processes.

Clinical & Pre-clinical Research Product Development Commercialization Startups Strategic Planning Modeling Operations/Project Management Team Leadership Client Relations Presentations Training & Development Workforce Planning Policy Development

PROFESSIONAL EXPERIENCE

DEPT. OF PHARMACOLOGY, SAHLGRENSKA ACADEMY, UNIVERSITY OF GOTHENBURG, 2007-01 – Present

Gothenburg, Sweden

Leading Swedish university. The Sahlgrenska Academy offers programs in pharmacy, medicine, odontology and other healthcare sciences. 6,500 students and 1,600 faculty including 2000 winner of Nobel prize in medicine.

Associate Professor of Pharmacology

Coordinate and implement multiple doctoral and Master’s-level pre-clinical and clinical research projects in neuropsychopharmacology; lead research taking preclinical hypotheses to clinical proof-of-concept studies. Lead international seminars and workshops. Successfully obtained major research funding grants.

COGNITE AB, Gothenburg, Sweden 2010-03 – Present

Startup currently developing first commercial product Eidisine™, a patented food additive that improves cognitive performance.

Co-founder

Co-founder and operational leader of promising startup focusing on identification, development and commercialization of neuro-active products. Lead research; responsible for development of first pipeline product Eidisine™. Created effective, cross-functional team of experts in business development and marketing, intellectual property law and operations. Direct company operations.

• Successfully led research identifying valuable new compound, led development into commercially viable new product.

• Negotiated major investment to commercialize Eidisine™ including significant financing by Swedish venture capital and forecast product launch within 30 months.

NEUROSEARCH SWEDEN AB, Gothenburg, Sweden 2010-06 – 2011-12

Pharmaceutical company based in Scandinavia with focus on developing new drugs for the treatment of central nervous system disorders.

Senior Research Scientist in Pharmacology

Lead and evaluate multiple discovery phase neuropharmacological research products with focus on strategic evaluation at preclinical and clinical stages for development and commercialization. Perform pharmacological modeling for psychiatric and neurological indications.

• Manage teams from technicians to Ph.D. level.

• Lead key projects for transitioning discovery phase substances into candidate drugs.

• Project leader for developing new animal models to trace NeuroSearch from psychiatric to neurological indications.

YALE UNIVERSITY SCHOOL OF MEDICINE, New Haven, CT 2005 -- 2006

Post-doctoral Researcher, Department of Psychiatry

Investigated neronal synchronization in order to identify cognitive processes using Rhesus monkey modeling.

DEPT. OF PHARMACOLOGY, SAHLGRENSKA ACADEMY, UNIVERSITY OF GOTHENBURG, January – August, 2005

Gothenburg, Sweden

Research Assistant, Department of Pharmacology

Developed and deployed new experiments to clarify cognitive dysfunctions.

ASTRAZENECA R&D MÖLNDAL, Gothenburg, Sweden June – August, 2000

Consulting Researcher

Tested and analyzed new compounds.

EDUCATION

Ph.D. in Pharmacology (focus on in-vivo pharmacology and behavioral models assessing cognitive processes) The Sahlgrenska Academy at University of Gothenburg, Sweden, 2004

Master of Science Degree, Molecular Biology, The Sahlgrenska Academy at University of Gothenburg, Sweden, 2000

Author of 24 original research papers in the field of neuropsychopharmacology

EXTRACURRICULAR ACTIVITIES, SKILLS AND INTERESTS

Fluent in Swedish and English, with living experience in the U.S., Sweden, and Israel

Interest in traveling, photography, skiing and sailing; enjoy working in teams

Participated as an expert commentator twice on national Swedish Television regarding patients with schizophrenia

In the first official Swedish Tsunami rescue team sent to Thailand, awarded “Lifesaver of the Year” by Swedish Magen David Adom

Have legal working papers in order, do not require a visa to work in the U.S. as I

Contact this candidate